Peer-reviewed veterinary case report
Vagal nerve stimulation effects on left atrium in dogs with heart
By Kusunose, Kenya et al.·Published in Circulation. Heart failure·2014·Cleveland Clinic, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Impact of vagal nerve stimulation on left atrial structure and function in a canine high-rate pacing model.
- Species:
- dog
Plain-English summary
A group of 15 mongrel dogs with heart failure were studied to see how vagal nerve stimulation (VNS) affected their heart's left atrium. The dogs were divided into two groups: one received VNS while the other did not. After 8 weeks of high-rate pacing, the dogs that received VNS showed better left atrial function and less fibrosis (scarring) compared to the control group. This suggests that VNS could be a promising treatment to help improve heart function in dogs with heart failure.
People also search for: dog heart failure treatment · vagal nerve stimulation for dogs · improving dog heart function · dog heart disease symptoms
Abstract
BACKGROUND: Cervical vagal nerve stimulation (VNS) can improve left ventricular dysfunction in the setting of heart failure (HF). However, little is known about the impact of VNS on left atrial (LA) function. The aim of this study was to compare LA mechanics and histology between control and VNS-treated animals during HF development. METHODS AND RESULTS: Fifteen mongrel dogs were randomized into control (n=7) and VNS (n=8) groups. All dogs underwent 8 weeks of high-rate ventricular pacing (at 220 beats per minute for the first 4 weeks to develop HF and another 4 weeks at 180 beats per minute to maintain HF). LA contractile function (LA negative peak strain), conduit function (LA positive peak strain), and reservoir function (LA total strain) were measured from speckle tracking in 2 groups. At the end of the terminal study, the LA appendage was obtained. Baseline LA strains were comparable in the control and VNS-treated dogs. At 4 and 8 weeks of ventricular pacing, all LA strains were decreased and LA volumes were increased in the control group compared with the VNS group (P<0.05). Histological evaluation of the left atrium revealed that percent fibrosis was significantly lower in the VNS versus the control group (8±1% versus 13±1%; P<0.001). Finally, transmitral flow showed decreased atrial contribution to left ventricular filling in the control group (P<0.05). CONCLUSIONS: VNS improved LA function and volumes and suppressed LA fibrosis in the canine high-rate ventricular pacing model. VNS is a novel and potentially useful therapy for improving LA function during HF.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/24397925/